Suppression of Tumor Angiogenesis by Nonsteroidal Anti-Inflammatory Drugs: A New Function for Old Drugs

There is solid epidemiological evidence demonstrating that the regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) reduces the risk of developing colorectal cancer, and to a lesser extent gastric and esophageal cancers[1]. Importantly, NSAIDs suppress colon polyp formation and progression in patients diagnosed with familial adenomatous polyposis coli (APC)[2]. In many animal studies, NSAIDs have been shown to prevent tumor formation and slow tumor progression, thus confirming and extending the clinical observations[3,4,5]. Recent findings have demonstrated that NSAIDs inhibit angiogenesis, suggesting that the tumor suppressive activity of these drugs may be due, at least in part, to their ability to inhibit tumor angiogenesis[6]. The study of the mechanism by which NSAIDs suppress tumor angiogenesis, is matter of intense research.

• Publication year

  2001

• Venue

  TheScientificWorldJournal

• Publication date

  2001-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1100/tsw.2001.396PMID 12805715PMCID 6084148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse by Rofecoxib , a Specific Cyclooxygenase-2 Inhibitor 716 ∆ Apc Chemoprevention of Intestinal Polyposis in the Updated Version

  2001cited by this paper
• Magnetic resonance imaging applications in the evaluation of tumor angiogenesis.

  2001cited by this paper
• NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

  2001cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Application of CT in the investigation of angiogenesis in oncology.

  2000cited by this paper
• Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents.

  2000cited by this paper
• Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

  1999cited by this paper
• Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing

  1999cited by this paper
• The role of cyclooxygenases in inflammation, cancer, and development

  1999cited by this paper
• Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.

  1999cited by this paper
• Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.

  1998cited by this paper
• Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Cyclooxygenase in biology and disease

  1998cited by this paper
• The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan.

  1997cited by this paper
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis

  1995cited by this paper
• Requirement of vascular integrin alpha v beta 3 for angiogenesis.

  1994cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids.

  1992cited by this paper
• Aspirin use and reduced risk of fatal colon cancer.

  1991cited by this paper

• The Potential Preventive and Therapeutic Roles of NSAIDs in Prostate Cancer

  2023cites this paper
• Neoplastic Disease

  2021cites this paper
• Synthesis and anticancer activity of open-resorcinarene conjugates.

  2020cites this paper
• Pharmacological Evaluation of Novel Organoiron Dendrimers as Antimicrobial and Anti-Inflammatory Agents.

  2020cites this paper
• PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel.

  2016cites this paper
• Inhibitory effect of ibuprofen on tumor survival and angiogenesis in gastric cancer cell

  2015cites this paper
• Ca2+ signalling in endothelial progenitor cells: a novel means to improve cell-based therapy and impair tumour vascularisation.

  2014cites this paper
• Pharmacotherapy of cancer pain in dogs and cats suffering from cancer.

  2010cites this paper